Diabetes Drug Shows Slight Effect on Dementia in German Study

in 2014, Benjamin Wolozin, Bloomberg, Centers & Institutes in the News, Newsmakers, School of Medicine
July 14th, 2014

faculty-wolozin3Bloomberg
Benjamin Wolozin, School of Medicine, Alzheimer’s Disease Center

Older Germans who took Takeda Pharmaceutical Co. (4502)’s diabetes medicine Actos were slightly less likely to develop dementia, according to a study that may do little to resolve questions about the drug’s usefulness…

Expert quote:

“It was very important to do this study. However, it’s actually almost surprising to me that the lowering of relative risk was so weak.”

View full article

Comments are closed.